This followed the same trend as BRCA1 knockdown (although c-Myc siRNA did not reach statistical significance).
← all excerpts
Thromboxane A2 receptor (TBXA2R) is a potent survival factor for triple negative breast cancers (TNBCs).
1
—
—
This followed the same trend as BRCA1 knockdown (although c-Myc siRNA did not reach statistical significance).